Correction: Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial.
Prostate Cancer Prostatic Dis
; 25(3): 597, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-34848822
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Prostate Cancer Prostatic Dis
Journal subject:
ENDOCRINOLOGIA
/
NEOPLASIAS
/
UROLOGIA
Year:
2022
Type:
Article
Affiliation country:
United States